W. Elliott

Daniel Hanley, Robert W Dubois, Susan C Fagan, 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Job strain in men, but not in women, predicts a significant rise in blood pressure after 6.5 years of follow-up

W. Elliott, 2008 .

Long-term Blood Pressure Fluctuation and Cerebrovascular Disease in an Elderly Cohort

W. Elliott, 2011 .

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

W. Elliott, 2011 .

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

W. Elliott, 2011 .

Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension

W. Elliott, 2011 .

Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

W. Elliott, 2011 .

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

W. Elliott, 2009 .

Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

W. J. Elliott, W. Elliott, 2010 .

Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.

Mary F. Johnson, H. Black, W. White, 2001, American journal of hypertension.

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study

W. Elliott, 2008 .

Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers

W. Elliott, 2000, Current hypertension reports.

Home Blood Pressure Management and Improved Blood Pressure Control: Results From a Randomized Controlled Trial

W. Elliott, 2012 .

Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial

W. Elliott, 2011 .

A multifaceted intervention to improve blood pressure control: The Guideline Adherence for Heart Health (GLAD) study

W. Elliott, 2010 .

Home blood pressure telemonitoring improves hypertension control in general practice: The TeleBPCare study

W. Elliott, 2010 .

Two Self-management Interventions to Improve Hypertension Control: A Randomized Trial

W. J. Elliott, W. Elliott, 2010 .

Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: A Randomized Controlled Trial

W. J. Elliott, W. Elliott, 2009 .

Chapter 52 – European and British Guidelines on Hypertension

G. Mancia, G. Grassi, B. Williams, 2012 .

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.

R. Zeldin, D. Calhoun, W. Elliott, 2001, Clinical therapeutics.

Reliability of palpation of the radial artery compared with auscultation of the brachial artery in measuring SBP

W. Elliott, 2012 .

Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts

W. Elliott, 2012 .

Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study

W. Elliott, 2010 .

Self-Measurement of Blood Pressure at Home Reduces the Need for Antihypertensive Drugs: A Randomized, Controlled Trial

W. Elliott, 2009 .

Importance of Therapy Intensification and Medication Nonadherence for Blood Pressure Control in Patients With Coronary Disease

W. Elliott, 2009 .

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomised trials

W. Elliott, 2009 .

Management of hypertension in the very elderly patient.

W. Elliott, William J Elliott, 2004, Hypertension.

Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion

W. Elliott, 2012 .

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

W. Elliott, 2009 .

Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative

W. Elliott, 2008 .

Renovascular Hypertension: An Update

W. Elliott, 2008, Journal of clinical hypertension.

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

W. Elliott, 2009 .

Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs: A Nested Case–Control Study

W. Elliott, 2011 .

Drug Delivery Systems for Treatment of Systemic Hypertension

W. Elliott, L. Prisant, L. Prisant, 2003, Clinical pharmacokinetics.

Feasibility of Treating Prehypertension with an Angiotensin-Receptor BlockerJulius S, for the Trial of Preventing Hypertension (TROPHY) Study Investiga tors (Univ of Michigan, Ann Arbor; et al): N Engl J Med 354:1685–1697, 2006§

W. Elliott, 2007 .

Using Diuretics in Practice—One Opinion

W. Elliott, Richard H. Grimm, Jr, 2008, Journal of clinical hypertension.

Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events

W. Elliott, 2012 .

Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension

W. Elliott, 2009 .

Hypertension Awareness, Treatment, and Control — Continued Disparities in Adults: United States, 2005-2006

W. J. Elliott, W. Elliott, 2009 .

Preeclampsia and Cardiovascular Disease Death: Prospective Evidence From the Child Health and Development Studies Cohort

W. Elliott, 2011 .

Chapter 21 – Angiotensin Receptor Blockers

H. Black, W. Elliott, 2007 .

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

W. Elliott, 2012 .

Implications of Recently Published Trials of Blood Pressure–Lowering Drugs in Hypertensive or High-Risk Patients

W. Elliott, 2011 .

Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction

W. Elliott, 2011 .

Chapter 21 – Angiotensin Receptor Blockers

H. Black, W. Elliott, 2007 .

Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.

W. Elliott, M. Murphy, D. Gretler, 1990, Circulation.

Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.

W. White, W. Elliott, N. Shusterman, 1993, The American journal of medicine.

Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomized pilot trial

W. Elliott, 2009 .

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

W. Elliott, 2008 .

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

W. Elliott, 2012 .

Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke

W. Elliott, 2012 .

Association Between Blood Pressure and Survival over 9 Years in a General Population Aged 85 and Older

W. Elliott, 2007 .

Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function: A Randomized Trial

W. Elliott, 2010 .

Clinical features in the management of selected hypertensive emergencies.

W. Elliott, 2006, Progress in cardiovascular diseases.

Management of hypertension emergencies

W. Elliott, 2003, Current hypertension reports.

Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

W. Elliott, 2008 .

Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes

W. Elliott, 2011 .

Is a systolic blood pressure target <140mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial

W. Elliott, 2012 .

Chapter 44 – Resistant Hypertension

H. Black, W. Elliott, J. Setaro, 2013 .

Increases in Antihypertensive Prescriptions and Reductions in Cardiovascular Events in Canada

W. Elliott, 2010 .

Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension

W. Elliott, 2009 .

Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis

W. Elliott, 2008 .

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

W. Elliott, 2006 .

Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial

W. Elliott, 2008 .

Hypertension and Diabetes

W. Elliott, 2022, Diabetes and Kidney Disease.

Intensive antihypertensive treatment to the new lower blood pressure targets

W. Elliott, 1999, Current hypertension reports.

Association of higher diastolic blood pressure levels with cognitive impairment

W. Elliott, 2010 .

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis

W. Elliott, 2007 .

Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema

W. Elliott, 2012 .

Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials

W. Elliott, 2008 .

Does chocolate reduce blood pressure? A meta-analysis

W. Elliott, 2011 .

Strict Blood-Pressure Control and Progression of Renal Failure in Children

W. Elliott, 2010 .

Incidence and Characteristics of Angioedema Associated With Enalapril

W. Elliott, 2006 .

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Rahman M, for the ALLHAT Collaborative Research

W. Elliott, 2006 .

Adherence to Calcium Channel Blocker Therapy in Older Adults: A Comparison of Amlodipine and Felodipine

M. Tran, J. Menzin, M. Friedman, 2004, The Journal of international medical research.

Large Increases in Hypertension Diagnosis and Treatment in Canada After a Healthcare Professional Education ProgramOnysko J, for the Canadian Hypertension Education Program (Public Health Agency of Canada, Ottawa, Ont, Canada; et al): Hypertension 48:853–860, 2006§

W. Elliott, 2007 .

Effects on Peripheral and Central Blood Pressure of Cocoa With Natural or High-Dose Theobromine: A Randomized, Double-Blind Crossover Trial

W. Elliott, 2011 .

Effect of Cocoa and Tea Intake on Blood Pressure: A Meta-analysis

W. Elliott, 2008 .

Effects of Low Habitual Cocoa Intake on Blood Pressure and Bioactive Nitric Oxide: A Randomized Controlled Trial

W. Elliott, 2008 .

Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage

W. Elliott, 2011 .

Carotid Intima-Media Thickness and Antihypertensive Treatment: A Meta-Analysis of Randomized Controlled Trials

W. Elliott, 2007 .

Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring

W. Elliott, 2012 .

On-Treatment Diastolic Blood Pressure and Prognosis in Systolic Hypertension

W. Elliott, 2008 .

Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review

W. Elliott, 2008 .

Screening renal artery angiography in hypertensive patients undergoing coronary angiography and 6-month follow-up after ad hoc percutaneous revascularization

W. Elliott, 2011 .

Efficacy of Revascularization For Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis

W. Elliott, 2011 .

Accuracy of colour duplex ultrasound for the diagnosis of renal artery stenosis

W. Elliott, 2010 .

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial

W. Elliott, 2012 .

Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial

W. Elliott, 2012 .

Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials

W. Elliott, 2010 .

Effect of Telmisartan on Renal Outcomes: A Randomized Trial

S. Yusuf, G. Dagenais, J. Pogue, 2010 .

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

W. Elliott, 2009 .

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

W. Elliott, 2009 .

Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients

W. Elliott, 2008 .

Long-Term Renoprotective Effects of Standard Versus High Doses of Telmisartan in Hypertensive Nondiabetic NephropathiesAranda P, Segura J, Ruilope LM, et al (Hosp Regional Universitario Carlos Haya, Malaga, Spain; Hosp Universitario 12 de Octubre, Madrid): Am J Kidney Dis 46:1074–1079, 2005§

W. Elliott, 2007 .

Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)

W. Elliott, 2006 .

Angiotensin Receptor Blockers and Risk of Myocardial Infarction: Systematic Review

W. Elliott, 2006 .

The Role of Calcium Antagonists in Stroke Prevention

W. Elliott, Armin Bandari, 2005, Journal of clinical hypertension.

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Combination: Theory and Practice

W. Elliott, D. Sica, D. Sica, 2001, Journal of clinical hypertension.

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

G. Bakris, W. Hsueh, R. Toto, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.

H. Black, W. Elliott, J. Saseen, 1996, Hypertension.

Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency

W. Elliott, 2007 .

An Individualized Approach to the Hypertensive Patient with Renal Disease: Six Illustrative Case Studies

W. Elliott, 1995, Journal of clinical pharmacology.

Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults

W. Elliott, 2006 .

The J-Curve Between Blood Pressure and Coronary Artery Disease or Essential Hypertension: Exactly How Essential?

W. Elliott, 2010 .

In a population-based prospective study, no association between high blood pressure and mortality after age 85 yearsvan Bemmel T, Gussekloo J, Westendorp RGJ, et al (Leiden Univ Med Centre, The Netherlands): J Hypertens 24:287–292, 2006§

W. Elliott, 2007 .

SPECIAL REPORT Preserving Renal Function in Adults With Hypertension and Diabetes: A Consensus Approach

G. Bakris, W. Hsueh, R. Toto, 2000 .

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

A. Zanchetti, H. Black, J. Wittes, 1998, Controlled clinical trials.

Timing treatment to the rhythm of disease

W. Elliott, 2001, Postgraduate medicine.

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

W. Elliott, 2010 .

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

W. Elliott, 2008 .

Treatment of Hypertension in Patients 80 Years of Age or Older

W. Elliott, 2009 .

Effects of the DASH Diet Alone and in Combination With Exercise and Weight Loss on Blood Pressure and Cardiovascular Biomarkers in Men and Women With High Blood Pressure: The ENCORE Study

L. Watkins, W. Elliott, A. Hinderliter, 2011 .

Adherence to a DASH-Style Diet and Risk of Coronary Heart Disease and Stroke in Women

W. Elliott, 2009 .

Deteriorating Dietary Habits Among Adults With Hypertension: DASH Dietary Accordance, NHANES 1988-1994 and 1999-2004

W. Elliott, 2009 .

Bovine Casein Hydrolysate (C12 Peptide) Reduces Blood Pressure in Prehypertensive Subjects

W. Elliott, 2008 .

Antihypertensive Treatment and Development of Heart Failure in Hypertension: A Bayesian Network Meta-analysis of Studies in Patients With Hypertension and High Cardiovascular Risk

W. Elliott, 2011 .

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

W. Elliott, 2010 .

Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-Analysis

W. Elliott, 2012 .

Treatment With Drugs to Lower Blood Pressure and Blood Cholesterol Based on an Individual's Absolute Cardiovascular RiskJackson R, Lawes CMM, Bennett DA, et al (Univ of Auckland, New Zealand) Lancet 365:434-441, 2005§

W. Elliott, 2006 .

Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial

W. Elliott, 2011 .

Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial

W. Elliott, 2010 .

Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study

W. Elliott, Clare Gardham, 2009 .

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

W. Elliott, 2008 .

Diurnal Blood Pressure Pattern and Risk of Congestive Heart FailureIngelsson E, Björklund-Bodegård K, Lind L, et al (Uppsala Univ, Sweden; AstraZeneca Research and Development, Mölndal, Sweden): JAMA 295:2859–2866, 2006§

W. Elliott, 2007 .

Are Chlorthalidone and Hydrochlorothiazide Equivalent Blood‐Pressure‐Lowering Medications?

G. Bakris, W. Elliott, D. Chua, 2005, Journal of clinical hypertension.

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

W. Elliott, 2011 .

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study

W. Elliott, 2010 .

Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)

W. Elliott, 2010 .

Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks: Candesartan Antihypertensive Survival Evaluation in Japan Trial

W. Elliott, 2009 .

Long-Term Effects of Chlorthalidone Versus Hydrochlorothiazide on Electrocardiographic Left Ventricular Hypertrophy in the Multiple Risk Factor Intervention Trial

W. Elliott, 2012 .

Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk

W. Elliott, 2012 .

Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide: A Retrospective Cohort Analysis

W. Elliott, 2012 .

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

W. Elliott, 2011 .

Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study

W. Elliott, 2011 .

Changes in Serum Potassium Mediate Thiazide-Induced Diabetes

W. Elliott, 2010 .

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses

W. Elliott, 2010 .

Reduction in Blood Pressure With Statins: Results From the UCSD Statin Study, a Randomized Trial

W. Elliott, 2009 .

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

W. Elliott, 2009 .

Impact of New-Onset Diabetes Mellitus on Cardiac Outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Population

W. Elliott, 2008 .

Long-Term and Short-Term Changes in Antihypertensive Prescribing by Office-Based Physicians in the United States

W. Elliott, 2007 .

Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood PressureErnst ME, Carter BL, Goerdt CJ, et al (Univ of Iowa, Iowa City): Hypertension 47:352–358, 2006§

W. Elliott, 2007 .

Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Barzilay JI, for the ALLHAT Collaborative R

W. Elliott, 2007 .

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialLeenen FHH, for the Antihypertensive and Lipid-Lowering Treatment to Preven

W. Elliott, 2007 .

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Whelton PK, for the ALLHAT Collaborative Research Group (Tulane Univ, New Orleans, La; et

W. Elliott, 2006 .

Long-term Effect of Diuretic-based Therapy on Fatal Outcomes in Subjects With Isolated Systolic Hypertension With and Without Diabetes

W. Elliott, 2006 .

Chlorthalidone vs other low-dose diuretics.

W. Elliott, D. Chua, Kenneth L. Choi, 2004, JAMA.

Influence of Physicians' Management and Communication Ability on Patients' Persistence With Antihypertensive Medication

W. Elliott, 2011 .

Does Blood Pressure Lowering Treatment Prevents Dementia or Cognitive Decline in Patients With Cardiovascular and Cerebrovascular Disease?Feigin V, Ratnasabapathy Y, Anderson C (Univ of Auckland, New Zealand) J Neurol Sci 229-230:151-155, 2005§

W. Elliott, 2006 .

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

W. Elliott, 2011 .

Long-term Effects of Weight-Reducing Interventions in Hypertensive Patients: Systematic Review and Meta-analysis

W. Elliott, 2009 .

Risk Factors for Arterial Hypertension in Adults With Initial Optimal Blood Pressure: The Strong Heart Studyde Simone G, for the Strong Heart Study Investigators (Cornell Univ, New York; et al): Hypertension 47:162–167, 2006§

W. Elliott, 2007 .

Long-term Cardiovascular Outcomes in Men With Obstructive Sleep Apnoea-Hypopnoea With or Without Treatment With Continuous Positive Airway Pressure: An Observational Study

W. Elliott, 2006 .

Change in Body Mass Index and Its Impact on Blood Pressure: A Prospective Population StudyDloyvold WB, Midthjell K, Nilsen TIL, et al (Norwegian Univ of Science and Technology, Trondheim, Norway) Int J Obes 29:650-655, 2005§

W. Elliott, 2006 .

Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004

W. Elliott, 2008 .

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

W. Elliott, W. J. Elliott, 2008 .

Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study

W. Elliott, 2010 .

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

W. Elliott, 2012 .

Association Between Chlorthalidone Treatment of Systolic Hypertension and Long-term Survival

W. Elliott, 2012 .

Effects of Blood Pressure Levels on Case Fatality After Acute Stroke

W. Elliott, 2006 .

Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial

W. Elliott, 2011 .

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

W. Elliott, 2010 .

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

W. Elliott, 2009 .

Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study

W. Elliott, 2010 .

Association Between Blood Pressure Responses to the Cold Pressor Test and Dietary Sodium Intervention in a Chinese Population

W. Elliott, 2009 .

Premature deaths attributable to blood pressure in China: a prospective cohort study

W. Elliott, 2010 .

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.

H. Black, W. White, W. Elliott, 2001, American heart journal.

Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class

W. Elliott, 2012 .

Twenty-year cardiovascular and all-cause mortality trends and changes in cardiovascular risk factors in Gubbio, Italy: the role of blood pressure changes

W. Elliott, 2010 .

Hypertension Control at Physicians’ Offices in the United States

W. Elliott, 2009 .

Switching phlebotomy needles.

W. Elliott, 1991, Annals of internal medicine.

A Double‐Blind, Randomized, Placebo‐Controlled Comparison of the Metabolic Effects of Low‐Dose Hydrochlorothiazide and Indapamide

W. Elliott, M. Murphy, R. R. Weber, 1991, Journal of clinical pharmacology.

Hypertension in Women: The Women Take Heart Project

H. Black, D. Pandey, S. Hollenberg, 2003, Journal of clinical hypertension.

Influence of Diuretic Therapy on the Clonidine Suppression Test

G. Gramelspacher, W. Elliott, M. Murphy, 1991, Journal of clinical pharmacology.

Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

W. Elliott, 2009 .

Modulation of Blood Pressure by Central Melanocortinergic Pathways

W. Elliott, 2010 .

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

W. Elliott, 2011 .

Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome

W. Elliott, 2008 .

Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

W. Elliott, 2011 .

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

W. Elliott, P. Meyer, William J Elliott, 2007, The Lancet.

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

W. Elliott, 2012 .

Expertise: No Longer a Sine Qua Non for Guideline Authors?

K. Kario, G. Parati, G. Mancia, 2017, Hypertension.

Effects of Verapamil and Trandolapril in the Treatment of Hypertension

W. Frishman, W. Elliott, F. Messerli, 1998 .

Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up

W. Elliott, 2008 .

Circadian variation in blood pressure: implications for the elderly patient.

W. Elliott, 1999, American journal of hypertension.

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

W. Elliott, 2012 .

Dopamine and dopamine receptor agonists in cardiovascular therapy

W. Elliott, M. Murphy, 1990, Critical care medicine.

Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.

R. Childers, M. Moscucci, W. Elliott, 1992, Archives of internal medicine.

Antihypertensive Medication Use During Pregnancy and the Risk of Cardiovascular Malformations

W. Elliott, 2010 .

Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction.

D. Weir, W. Elliott, D. R. Weir, 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea

W. Elliott, 2008 .

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension

Christopher M O'Connor, Christopher P Cannon, Matthew Allison, 2015 .

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Christopher M O'Connor, Christopher P Cannon, Matthew Allison, 2015, Journal of the American College of Cardiology.

Therapy: Atenolol versus metoprolol tartrate—conflicting outcomes data

W. Elliott, S. Randhawa, 2014, Nature Reviews Nephrology.

Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels.

W. Elliott, M. Murphy, 1988, The American journal of medicine.

Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma.

W. Elliott, M. Murphy, J. Jarabak, 1989, Archives of internal medicine.

Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey

W. Elliott, 2007 .

Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension

W. Elliott, 2011 .

Call to Action on Use and Reimbursement for Home Blood Pressure Monitoring: Executive Summary: A Joint Scientific Statement From the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association

W. Elliott, 2009 .

subjectssympathetic neural activity in young normotensive Strength training reduces arterial blood pressure but

R. Brook, M. Rubenfire, S. Rajagopalan, 2015 .

Ketoconazole reduces elevated serum levels of 1,25-dihydroxy vitamin D in hypercalcemic sarcoidosis

W. Elliott, J. Lemann, R. Gray, 1990, Journal of endocrinological investigation.

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension

Christopher M O'Connor, Christopher P Cannon, Matthew Allison, 2015, Hypertension.

Expertise: no longer a sine qua non for guideline authors?

K. Kario, G. Parati, G. Mancia, 2017, Journal of hypertension.

Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker

W. Elliott, 2008 .

Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure ProgressionWang TJ, Evans JC, Meigs JB, et al (Framingham Heart Study, Mass; Harvard Med School, Boston) Circulation 111:1370-1376, 2005§

W. Elliott, 2006 .

Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment

W. Elliott, 2009 .

The costs of treating hypertension.

W. Elliott, 1996, Postgraduate medicine.

Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study

W. Elliott, 2008 .

Other forms of secondary hypertension

W. Elliott, 2012 .

Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial

W. Elliott, 2011 .

The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients with Obstructive Sleep Apnea Syndrome: Evidence From a Meta-analysis of Placebo-Controlled Randomized Trials

W. Elliott, 2008 .

Cardiovascular Outcomes in Framingham Participants With Diabetes: The Importance of Blood Pressure

W. Elliott, 2012 .

Comparison between angiotensin-converting enzyme Inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis

W. Elliott, 2009 .

Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study

W. Elliott, 2012 .

Chapter 23 – α-Blockers

J. Pool, W. Elliott, 2007 .

Long-term Changes in Blood Pressure in Extremely Obese Patients Who Have Undergone Bariatric Surgery

W. Elliott, 2007 .

Treatment of hypertension in patients 80years and older: the lower the better? A meta-analysis of randomized controlled trials

W. Elliott, 2011 .

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

W. Elliott, 2008 .

Clinical Features and Management of Selected Hypertensive Emergencies

W. Elliott, 2004, Journal of clinical hypertension.

Antihypertensive Therapies

W. Elliott, 2022, Diabetes and Kidney Disease.

Screening renal artery angiography in hypertensive patients undergoing coronary angiography and 6-month follow-up after ad hoc percutaneous revascularization

W. Elliott, 2011 .

Revascularization versus Medical Therapy for Renal-Artery Stenosis

W. Elliott, 2010 .

High prevalence of white-coat hypertension in Spanish resistant hypertensive patients.

W. Elliott, 2011, Hypertension.

Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic.

W. Elliott, M. Murphy, R. Karp, 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial

W. Elliott, 2010 .

Compliance strategies.

W. Elliott, 1994, Current opinion in nephrology and hypertension.

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial

P. Grambsch, A. Zanchetti, H. Black, 2001, Hypertension.

Prognostic Significance for Stroke of a Morning Pressor Surge and a Nocturnal Blood Pressure Decline: The Ohasama StudyMetoki H, Ohkubo T, Kikuya M, et al (Tohoku Univ, Sendai, Japan; Ohasama Hosp, Iwate, Japan): Hypertension 47:149–154, 2006§

W. Elliott, 2007 .

Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure

W. Elliott, 2008 .

CHAPTER 65 – Endocrine hypertension

W. Elliott, 2012 .

Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma

W. Elliott, 2008 .

Effect of Long-Acting Nifedipine on Mortality and Cardiovascular Morbidity in Patients With Symptomatic Stable Angina and Hypertension: The ACTION Trial

W. Elliott, 2006 .

Measuring blood pressure for decision making and quality reporting: where and how many measures?

W. Elliott, 2012 .

Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review

W. Elliott, 2012 .

Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

W. Elliott, 2007 .

Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy

W. Elliott, 2008 .

Aliskiren, an Orally Effective Renin Inhibitor, Provides Antihypertensive Efficacy Alone and in Combination With Valsartan

W. Elliott, 2008 .

Variation in Renin–Angiotensin System and Salt-Sensitivity Genes and the Risk of Diabetes Mellitus Associated With the Use of Thiazide Diuretics

W. Elliott, 2010 .

Determinants of masked hypertension in the general population: the Finn-Home study

W. Elliott, 2012 .

Screening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin ActivitySchwartz GL, Turner ST (Mayo Clinic, Rochester, Minn) Clin Chem 51:386-394, 2005§

W. Elliott, 2006 .

Antihypertensive Efficacy of Hydrochlorothiazide as Evaluated by Ambulatory Blood Pressure Monitoring: A Meta-Analysis of Randomized Trials

W. Elliott, 2012 .

Chapter 46 – Hypertensive Emergencies and Urgencies

J. Basile, S. Rehman, W. Elliott, 2013 .

Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

K. Uhlig, A. Earley, W. Elliott, 2012 .

Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension

W. Elliott, 2011 .

A006: Resistant hypertension in a tertiary care clinic: revisited

G. Bakris, H. Black, W. Elliott, 2000 .

Resistant or Difficult-to-Control Hypertension

W. Elliott, 2007 .

Should β Blockers Remain First Choice in the Treatment of Primary Hypertension? A Meta-AnalysisLindholm LH, Carlberg B, Samuelsson O (Umeá Univ, Sweden; Univ Hosp, Göteborg, Sweden) Lancet 366:1545-1553, 2005§

W. Elliott, 2006 .

Editorial on Ibrahim et al's “Clinical Pharmacology Studies in Patients with Renal Impairment: Past Experience and Regulatory Perspectives”

G. Bakris, W. Elliott, Susanne Swan, 2000, Journal of clinical pharmacology.

Better compliance to antihypertensive medications reduces cardiovascular risk

W. Elliott, 2012 .

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure

W. Elliott, 2010 .

Comparison of Two Strategies for Intensifying Antihypertensive Treatment Low-Dose Combination (Enalapril 1 Felodipine ER) Versus Increased Dose of Monotherapy (Enalapril)

W. Elliott, A. Gradman, M. Klibaner, 1999 .

Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive PatientsGradman AH, Schmieder RE, Lins RL, et al (Western Pennsylvania Hosp, Pittsburgh; Univ of Erlangen-Nürnberg, Germany; Jan Palfijn-Gallifort, Mer

W. Elliott, 2006 .

Arrhythmias and increased neuro-endocrine stress response during physicians' night shifts: a randomized cross-over trial

W. Elliott, 2010 .

Ethnic Differences in Blood Pressure Control Among Men at Veterans Affairs Clinics and Other Health Care SitesRehman SU, Hutchison FN, Hendrix K, et al (Med Univ of South Carolina, Charleston) Arch Intern Med 165:1041-1047, 2005§

W. Elliott, 2006 .

Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial

W. Elliott, 2010 .

Hypertension—Time to Move on

W. Elliott, 2006 .

Randomized Trial of Acupuncture to Lower Blood Pressure

W. Elliott, 2008 .

Endocrine hypertension

W. Elliott, 2019, Nephrology Secrets.

Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study

W. Elliott, 2012 .

F11 - Costs associated with changing antihypertensive drug monotherapy: “Preferred” vs. “Alternative” therapy

W. Elliott, 1995 .

Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

W. Elliott, 2009 .

Changing the Timing of Antihypertensive Therapy to Reduce Nocturnal Blood Pressure in CKD: An 8-week Uncontrolled Trial

W. Elliott, 2009 .

Ambulatory Blood Pressure Monitoring and Risk of Cardiovascular Disease: A Population Based Study

W. Elliott, 2007 .

Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus

W. Elliott, 2010 .

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Peter Sleight, Janet Wittes, James D Neaton, 2003, JAMA.

Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis

W. Elliott, 2008 .

Who is an expert? Reply

K. Kario, G. Parati, G. Mancia, 2017 .

Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension

G. Saade, G. Pearson, E. Thom, 2011 .

Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart AssociationAppel LJ, Brands MW, Daniels SR, et al (Johns Hopkins Univ; Med College of Georgia; Cincinnati Children's Hosp, Ohio; et al): Hypertension 47:296–308, 2006§

W. Elliott, 2007 .

Manipulation of rat brain fatty acid composition alters volatile anesthetic potency.

P. Needleman, W. Elliott, J. Lefkowith, 1986, The Journal of clinical investigation.

Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease

W. Elliott, 2011 .

Age-Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community-Based Prospective Cohort Study

W. Elliott, 2008 .

Prevalence of Resistant Hypertension in the United States, 2003–2008

W. Elliott, 2012 .

Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women

W. Elliott, 2010 .

Prehypertension during Young Adulthood and Coronary Calcium Later in Life

W. Elliott, 2009 .

Arachidonic acid metabolism by rabbit fetal membranes of various gestational ages.

P. Needleman, W. Elliott, M. Bloch, 1984, Prostaglandins.

Essential fatty acid deficiency: a new look at an old problem.

P. Needleman, W. Elliott, J. Lefkowith, 1986, Prostaglandins, leukotrienes, and medicine.

Treatment: drug therapy of hypertension.

W. Elliott, 2015, Journal of the American Society of Hypertension : JASH.

The metabolic transformations of columbinic acid and the effect of topical application of the major metabolites on rat skin.

P. Needleman, W. Elliott, H. Sprecher, 1985, The Journal of biological chemistry.

Systemic hypertension.

W. Elliott, 2007, Current problems in cardiology.

Sodium and Potassium Intake and Mortality Among US Adults: Prospective Data From the Third National Health and Nutrition Examination Survey

W. Elliott, 2012 .

The costs of treating hypertension: what are the long-term realities of cost containment and pharmacoeconomics?

W. Elliott, 1996, Postgraduate medicine.

Reducing the Expenditures and Workload Associated With VA Partial-Fill Prescription Processing.

W. Elliott, Jennifer C Nazarchyk, Sarah Carlisle, 2018, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

Resistant hypertension revisited: a comparison of two university-based cohorts.

H. Black, W. Elliott, Amy Folker, 2005, American journal of hypertension.

Calcium-dependent oxidation of 5,8,11-icosatrienoic acid by the cyclooxygenase enzyme system.

P. Needleman, W. Elliott, H. Sprecher, 1986, The Journal of biological chemistry.

Maytansinoids. Synthesis of a fragment of known absolute configuration involving chiral centers C-6 and C-7.

W. Elliott, J. Fried, 1976, The Journal of organic chemistry.

Chapter 13 – The Natural History of Untreated Hypertension

W. Elliott, 2007 .

Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

H. Black, D. Weir, W. Elliott, 2000, Archives of internal medicine.

Glucose and cholesterol elevations during thiazide therapy: intention-to-treat versus actual on-therapy experience.

W. Elliott, 1995, The American journal of medicine.

Cardiovascular risk factors.

W. Elliott, 1994, Postgraduate medicine.

Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects

W. Elliott, S. Jurca, 2016, Current Hypertension Reports.

Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease: A Cost-Effectiveness Analysis

W. Elliott, 2011 .

Circadian variation in the timing of stroke onset: a meta-analysis.

W. Elliott, W J Elliott, 1998, Stroke.

Special Situations in the Management of Hypertension

H. Black, W. Elliott, 2001 .

National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants

W. J. Elliott, W. Elliott, 2012 .

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

W. Elliott, 2010 .

Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

C. O'connor, B. Gersh, S. Oparil, 2015, Journal of the American Society of Hypertension : JASH.

Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment

M. Maitland, M. Ratain, H. Black, 2009, Clinical Cancer Research.

AHA / ACC / ASH Scientific Statement Treatment of Hypertension in Patients With Coronary Artery Disease

C. O'connor, B. Gersh, S. Oparil, 2015 .

Should β Blockers No Longer Be Considered First-line Therapy for the Treatment of Essential Hypertension Without Comorbidities?

W. Elliott, W. K. Childers, 2011, Current cardiology reports.

Transport of thyroid hormones in serum and cerebrospinal fluid.

W. Elliott, G. Hagen, Garrett A. Hagen, 1973, The Journal of clinical endocrinology and metabolism.

Influence of Kaolin—Pectin Suspension on Steady‐State Plasma Digoxin Levels

W. Elliott, T. Gilbertson, K. Albert, 1981, Journal of clinical pharmacology.

Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline

W. Elliott, 2009 .

Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function.

P. Gorelick, B. Materson, D. Nyenhuis, 2012, Journal of the American Society of Hypertension : JASH.

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.

H. Black, W. White, W. Elliott, 1998, The American journal of cardiology.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

W. J. Elliott, W. Elliott, 2010 .

Differential effects of antihypertensive drugs on new-onset diabetes?

W. Elliott, 2005, Current hypertension reports.

Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

W. Elliott, 2012 .

Perindopril arginine + amlodipine for the treatment of hypertension in the USA

W. Elliott, 2015, Expert opinion on pharmacotherapy.

Rationale for a single-pill combination of perindopril arginine and amlodipine besylate.

W. Elliott, 2015, Journal of the American Society of Hypertension : JASH.

Blood Pressure Control and Primary Prevention of Stroke: Summary of Clinical Trial Data

W. Elliott, 2011 .

Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention

W. Elliott, Kenneth L. Choi, 2005, Current hypertension reports.

Cardiovascular Events in Hypertension Trials of Angiotensin‐Converting Enzyme Inhibitors

W. Elliott, 2005, Journal of clinical hypertension.

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation

W. Elliott, Evgeny A Bistrika, 2018, Expert opinion on drug safety.

Hypertension in Diabetes Mellitus

W. Elliott, William J. Elliott, 2014 .

Antihypertensive and Other Treatments in Early Stages of Diabetic Nephropathy

W. Elliott, 2014 .

'Hot topics' in hypertension.

W. Elliott, 2012, Current opinion in cardiology.

Management of Resistant Hypertension

W. Elliott, 2011 .

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

W. Elliott, 2009 .

A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease Patients

C. Pepine, R. Cooper-DeHoff, W. Elliott, 2005, Journal of clinical hypertension.

Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study

W. Elliott, 2011 .

The Misdiagnosis of Hypertension: The Role of Patient Anxiety

W. Elliott, 2010 .

Chapter 21 – The Concept of Total Risk

H. Black, W. Elliott, 2005 .

The Economic Impact of Hypertension

W. Elliott, William J. Elliott, 2003, Journal of clinical hypertension.

Hypertension in patients with diabetes

R. Toto, W. Elliott, G. Bakris, 2000, Postgraduate medicine.

46 – Hypertensive Emergencies and Urgencies

W. Elliott, 2018 .

Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States

W. Elliott, 2008 .

Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans

R. A. Silverman, W. Elliott, R. Tripathi, 1991, Clinical pharmacology and therapeutics.

Altered Blood Pressure Progression in the Community and Its Relation to Clinical Events

W. Elliott, 2009 .

Persistence, Adherence, and Risk of Discontinuation Associated with Commonly Prescribed Antihypertensive Drug Monotherapies

G. Skrepnek, W. Elliott, C. Plauschinat, 2007, The Journal of the American Board of Family Medicine.

Graded Blood Pressure Reduction in Hypertensive Outpatients Associated With Use of a Device to Assist With Slow Breathing

H. Black, J. Izzo, W. White, 2004, Journal of clinical hypertension.

One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension

H. Black, W. Frishman, W. Elliott, 2001, Hypertension.

Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial

W. Elliott, 2009 .

Underdiagnosis of Hypertension in Children and Adolescents

W. J. Elliott, W. Elliott, 2008 .

Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort

W. Elliott, 2008 .

Are Blood Pressure Predictors of Cardiovascular Disease Mortality Different for Prehypertensives Than for Hypertensives?Greenberg (Brooklyn College of the City Univ of New York): Am J Hypertens 19:454–461, 2006§

W. Elliott, 2007 .

Community-Based Interventions to Promote Blood Pressure Control in a Developing Country: A Cluster Randomized Trial

W. Elliott, 2010 .

A Prospective Study of Body Mass Index and the Risk of Developing Hypertension in Men

W. Elliott, 2008 .

Racial/Ethnic Disparities in Prevalence, Treatment, and Control of Hypertension—United States, 1999-2002

W. Elliott, W. J. Elliott, 2006 .

Presence of baseline prehypertension and risk of incident stroke: A meta-analysis

W. Elliott, 2012 .

Improving Outcomes in Hypertensive Patients: Focus on Adherence and Persistence With Antihypertensive Therapy

W. Elliott, 2009, Journal of clinical hypertension.

Rationale for Establishing a Mechanism to Increase Reimbursement to Hypertension Specialists

G. Bakris, W. White, B. Egan, 2013, Journal of clinical hypertension.

Chapter 59 – Resistant Hypertension

W. Elliott, William J. Elliott, 2007 .

Prevalence, Awareness, Treatment, and Control of Hypertension: United States National Health and Nutrition Examination Survey 2001–2002

W. Elliott, 2007 .

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region

P. Grambsch, A. Zanchetti, H. Black, 2005, Journal of hypertension.

Optimizing medication adherence in older persons with hypertension

W. Elliott, William J. Elliott, 2004, International Urology and Nephrology.

Treatment of Young Subjects at High Familial Risk of Future Hypertension With an Angiotensin-Receptor Blocker

W. Elliott, 2008 .

Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative

W. Elliott, 2008 .

Calcium Channel Blockers

W. Elliott, C. Ram, 2011, Journal of clinical hypertension.

Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial

W. Elliott, 2009 .

From the American Heart Association Beyond Medications and Diet : Alternative Approaches to Lowering Blood Pressure : A

M. Rubenfire, S. Rajagopalan, L. Appel, 2013 .

Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial

W. J. Elliott, W. Elliott, 2012 .

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

W. J. Elliott, W. Elliott, 2010 .

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories

W. J. Elliott, W. Elliott, 2009 .

Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

W. Elliott, 2012 .

Female sexual dysfunction in essential hypertension: a common problem being uncovered

W. Elliott, 2008 .

High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome: The Strong Heart Study

W. Elliott, 2010 .

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

W. Elliott, 2010 .

Cyclic and circadian variations in cardiovascular events.

W. Elliott, 2001 .

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

W. Elliott, 2009 .

Management of High Blood Pressure in Blacks: An Update of the International Society on Hypertension in Blacks Consensus Statement

W. Elliott, 2011 .

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

W. Elliott, 2010 .

The cost-effectiveness of interventions designed to reduce sodium intake

W. Elliott, 2012 .

Is fixed combination therapy appropriate for initial hypertension treatment?

W. Elliott, 2002, Current hypertension reports.

Chapter 8 – Secondary Hypertension: Renovascular Hypertension

W. Elliott, 2007 .

Generic Drugs for Hypertension: Are They Really Equivalent?

R. Cooper-DeHoff, W. Elliott, 2013, Current Hypertension Reports.

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

M. Maitland, G. Bakris, H. Black, 2010, Journal of the National Cancer Institute.

Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects

W. Elliott, 1996, Clinical pharmacology and therapeutics.

Effects of potassium-sparing versus thiazide diuretics on glucose tolerance: new data on an old topic.

W. Elliott, 2012, Hypertension.

Interventions to Enhance Medication Adherence in Chronic Medical Conditions: A Systematic Review

W. J. Elliott, W. Elliott, 2008 .

Heart Failure in ALLHAT: Did Blood Pressure Medication at Study Entry Influence Outcome?

W. Elliott, 2010 .

Increased all-cause and cardiac morbidity and mortality associated with the diagonal earlobe crease: a prospective cohort study.

T. Karrison, W. Elliott, T. Karrison, 1991, The American journal of medicine.

Chapter 24 – New Drugs for Hypertension

W. Elliott, 2012 .

Long-term Effects of Renin-Angiotensin System–Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans

W. Elliott, 2009 .

How Pharmacists Can Assist Physicians With Controlling Blood Pressure

W. Elliott, B. Carter, A. Zillich, 2003, Journal of clinical hypertension.

What Factors Contribute to the Inadequate Control of Elevated Blood Pressure?

W. Elliott, 2008, Journal of clinical hypertension.

Drug Interactions and Drugs That Affect Blood Pressure

W. Elliott, 2006, Journal of clinical hypertension.

Racial Differences in Diurnal Blood Pressure and Heart Rate Patterns: Results From the Dietary Approaches to Stop Hypertension (DASH) Trial

W. Elliott, 2009 .

Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.

F. Messerli, W. Frishman, W. Elliott, 1998, American journal of hypertension.

Novel Approach to Examining First Cardiovascular Events After Hypertension OnsetLloyd-Jones DM, Leip EP, Larson MG, et al (Northwestern Univ, Chicago; NIH, Framingham, Mass) Hypertension 45:39-45, 2005§

W. J. Elliott, W. Elliott, 2006 .

Blood Pressure Tracking

W. Elliott, 1997, Journal of cardiovascular risk.

Alcohol Consumption and Risk for Coronary Heart Disease among Men with Hypertension

W. Elliott, 2008 .

Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

W. Elliott, 2012 .

Effect of Ramipril on the Incidence of DiabetesGerstein HC, and the DREAM Trial Investigators (McMaster Univ, Hamilton, Canada; et al): N Engl J Med 355:1551–1562, 2006§

W. Elliott, 2007 .

Ear lobe crease and coronary artery disease. 1,000 patients and review of the literature.

W. Elliott, W J Elliott, 1983, The American journal of medicine.

Blood Pressure Change and Risk of Hypertension Associated With Parental Hypertension: The Johns Hopkins Precursors Study

W. Elliott, 2009 .

Detection, treatment, and control of adult hypertension in northwest Indiana. Ispat Inland/United Steelworkers of America Health Care Network.

W. Elliott, A. Stemer, S. Toth, 1999, American journal of hypertension.

What should be the blood pressure target for diabetic patients?

W. Elliott, 2011, Current opinion in cardiology.

Treatment blood pressure targets for hypertension

W. Elliott, 2010 .

Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study

W. Elliott, 2011 .

Major Congenital Malformations after First-Trimester Exposure to ACE InhibitorsCooper WO, Hernandez-Diaz S, Arbogast PG, et al (Vanderbilt Univ School of Medicine, Nashville; Boston Univ): N Engl J Med 354:2443–2451, 2006§

W. Elliott, 2007 .

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

W. Elliott, 2011 .

Do the Blood Pressure Effects of Nonsteroidal Antiinflammatory Drugs Influence Cardiovascular Morbidity and Mortality?

W. Elliott, 2010, Current hypertension reports.

Stereocontrolled synthesis of alpha-multistriatin, an essential component of the aggregation pheromone for the European elm bark beetle.

W. Elliott, J. Fried, 1976, Journal of Organic Chemistry.

Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control GoalsOkonofua EC, Simpson KN, Jesri A, et al (Med Univ of South Carolina, Charleston; Ralph H Johnson Veterans Affairs Med Ctr, Charleston, SC): Hypertension 47:345–351, 2006§

W. Elliott, 2007 .

Treatment of Hypertension in PatientsWith Coronary Artery Disease

B. Gersh, S. Oparil, C. Cannon, 2022 .

Synthesis of multistriatin enantiomers and their action onScolytus multistriatus (Coleoptera:Scolytidae)

W. Elliott, G. N. Lanier, J. Fried, 1979, Journal of Chemical Ecology.

Calcium Antagonists in Hypertension

H. Black, W. Elliott, 2001, Blood pressure.

Comparison of two noninvasive screening tests for renovascular hypertension.

W. Martin, W. Elliott, M. Murphy, 1993, Archives of internal medicine.

Culturally Appropriate Storytelling to Improve Blood Pressure: A Randomized Trial

W. J. Elliott, W. Elliott, 2012 .

Network meta-analysis of heart failure prevention by antihypertensive drugs.

W. Elliott, P. Meyer, S. Basu, 2011, Archives of internal medicine.

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

W. Elliott, 2012 .

Blood-Pressure Control for Renoprotection in Patients With Nondiabetic Chronic Renal Disease (REIN-2): Multicentre, Randomised Controlled Trial

W. Elliott, 2006 .

Antihypertensive Efficacy of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist, as Assessed by Ambulatory Blood Pressure Measurements

J. Izzo, W. Elliott, J. Neutel, 2002, Journal of clinical hypertension.

Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease

W. Elliott, 2012 .

Device-guided breathing to lower blood pressure: case report and clinical overview.

J. Izzo, W. Elliott, William J Elliott, 2006, MedGenMed : Medscape general medicine.

Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials

W. Elliott, 2009 .

Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension.

W. Elliott, M. Murphy, D. Gretler, 1993, Journal of human hypertension.

Efficacy and safety of perindopril arginine + amlodipine in hypertension.

G. Bakris, W. Elliott, J. Whitmore, 2014, Journal of the American Society of Hypertension : JASH.

Angiotensin Receptor Blockade and Arterial Compliance in Chronic Kidney Disease: A Pilot Study

G. Bakris, G. Chertow, W. Elliott, 2005, American Journal of Nephrology.

A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster-Randomized Controlled Trial

W. Elliott, 2010 .

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

W. Elliott, 2009 .

Incident diabetes in clinical trials of antihypertensive drugs – Authors' reply

W. Elliott, P. Meyer, 2007, The Lancet.

Biofeedback for hypertension: a systematic review

W. Elliott, 2011 .

Behavioral Neurocardiac Training in Hypertension: A Randomized, Controlled Trial

W. Elliott, 2011 .

An increase in the number of deaths in the United States in the first week of the month.

W. Elliott, A. Stemer, S. Toth, 1999, The New England journal of medicine.

Differential risks of stroke in pharmacotherapy on uncomplicated hypertensive patients

W. Elliott, 2010 .

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis

W. Elliott, W. J. Elliott, 2010 .

Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood PressureAw T-J, Haas SJ, Liew D, et al (Monash Univ, Melbourne, Australia) Arch Intern Med 165:490-496, 2005§

W. Elliott, 2006 .

Impact of the ALLHAT/JNC7 Dissemination Project on Thiazide-Type Diuretic Use

W. Elliott, 2011 .

Antihypertensive Prescriptions for Newly Treated Patients Before and After the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Guidelines

W. Elliott, 2010 .

Effect of Soy Nuts on Blood Pressure and Lipid Levels in Hypertensive, Prehypertensive, and Normotensive Postmenopausal Women

W. Elliott, 2008 .

Strict Blood-Pressure Control and Progression of Renal Failure in Children

W. Elliott, 2010 .

Diagnosis and Treatment of Renovascular Hypertension: A Cost-Benefit Analysis

W. Elliott, W. J. Elliott, 2006 .

Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review

J. Berlin, W. Kostis, J. Kostis, 2016, Journal of hypertension.

Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease.

W. Elliott, L. Powell, Lynda H. Powell, 1996, The American journal of medicine.

A unique cardiac cytosolic acyltransferase with preferential selectivity for fatty acids that form cyclooxygenase/lipoxygenase metabolites and reverse essential fatty acid deficiency.

P. Needleman, W. Elliott, H. Sprecher, 1985, Biochimica et biophysica acta.

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.

T. Ruddy, W. Elliott, T. Littlejohn, 1998, American journal of hypertension.

Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group.

W. Elliott, C. Hwang, A. Gradman, 1999, American journal of hypertension.

Which blood pressure measurement is more important in the elderly?

W. Elliott, 1999, Archives of internal medicine.

Insulin Therapy, Hyperglycemia, and Hypertension in Type 1 Diabetes Mellitus

W. Elliott, 2009 .

Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes

W. Elliott, 2009 .

Quality of Meta-Analyses for Randomized Trials in the Field of Hypertension: an Updated and Improved Systematic Review

J. Berlin, W. Kostis, J. Kostis, 2017, Current Hypertension Reports.

Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

C. O'connor, B. Gersh, S. Oparil, 2015, Journal of the American Society of Hypertension : JASH.

AHA/ASH Scientific Statement Treatment of hypertension in patients with coronary artery disease A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension

B. Gersh, S. Oparil, C. Cannon, 2015 .

Call for a Re-evaluation of the American Heart Association's Standpoint Concerning Device-Guided Slow Breathing Using the RESPeRATE Device

R. Brook, W. Elliott, 2013 .

Systematic discovery and evaluation of complement inhibitors.

N. Bauman, W. Elliott, B. Pease, 1981, Immunopharmacology.

Evaluation of the Suntech Accutracker. A novel noninvasive ambulatory blood pressure monitor.

W. Elliott, M. Murphy, K. Nelson, 1988, American journal of hypertension.

The eye in hypertension

W. Elliott, 2008 .

Management of Resistant Hypertension

W. Elliott, R. Holaj, 2011 .

W. Elliott, 2009 .

A comparison of two sphygmomanometers that may replace the traditional mercury column in the healthcare workplace

H. Black, W. Elliott, P. Young, 2007, Blood pressure monitoring.

Wednesday, May 15, 1:00 PM – 3.00 PM: Systolic hypertension: the challenge of our time: How to treat systolic hypertension: New insights from clinical trials

W. Elliott, 2002 .

Antihypertensive properties of a high‐dose combination of trandolapril and verapamil‐SR

F. Messerli, C. Pepine, W. Frishman, 2007, Blood pressure. Supplement.

W. Elliott, 2009 .

Strict Blood-Pressure Control and Progression of Renal Failure in Children

W. Elliott, 2010 .

What is the prevalence of resistant hypertension in the United States?

W. Elliott, Dustin R. Roberie, 2012, Current opinion in cardiology.

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

W. Elliott, 2012 .

Blood pressure (BP) as a biomarker for sorafenib (S), an inhibitor of the vascular endothelial growth factor (VEGF) signaling pathway.

M. Maitland, M. Ratain, W. Stadler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expertise: No Longer a Sine Qua Non for Guideline Authors?

K. Kario, G. Parati, G. Mancia, 2017, Hypertension.

Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

W. Elliott, 2011 .

Controversies regarding the recommendations of the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

W. Elliott, 1994, Comprehensive therapy.

Efficacy and safety of perindopril arginine + amlodipine in hypertension.

G. Bakris, W. Elliott, J. Whitmore, 2014, Journal of the American Society of Hypertension : JASH.

D. Hanley, M. Broder, R. Zorowitz, 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force

W. Elliott, 2009 .

Antihypertensive Treatment with and without Benazepril in Patients with Chronic Renal Insufficiency

G. Bakris, W. Elliott, A. Seto, 2002, PharmacoEconomics.

Compliance--and improving it--in hypertension.

W. Elliott, 2003, Managed care.